Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11413331 Immunoconjugates

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

April 2, 2018

Date of Patent

August 16, 2022

Patent Application Number

15943237

Patent Citations

US Patent 10344089 Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

US Patent 10761097 Method for the detection of a binding partner of a multispecific binder

US Patent 10562903 Bridged piperidine derivatives

US Patent 10718762 Cellular based fret assay for the determination of simultaneous binding

US Patent 10596173 Combination therapy of an HBV capsid assembly inhibitor and an interferon

US Patent 10934352 Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions

US Patent 10287352 Bispecific antibodies specific for PD1 and TIM3

US Patent 10392445 Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

Patent Citations Received

US Patent 12023368 Immunoconjugates

0

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11413331 Immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool